ALPHAMAB-B (09966) announced that on September 7, 2026, it spent HK$989,200 to repurchase 115,000 shares.
The buyback reflects the company's ongoing capital management strategy, with the repurchased shares potentially being used for employee incentive plans or other corporate purposes. The transaction was executed at prevailing market prices, and further repurchases may occur depending on market conditions and the company's financial position.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.